{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:10:08Z","timestamp":1792469408053,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000149","name":"Canadian Association of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007658","name":"Crohn's and Colitis Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000066","name":"Canadian Child Health Clinician Scientist Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1053\/j.gastro.2020.12.079","type":"journal-article","created":{"date-parts":[[2021,2,20]],"date-time":"2021-02-20T21:25:31Z","timestamp":1613856331000},"page":"669-680.e0","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)\u2014Part 1: Live Vaccines"],"prefix":"10.1053","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-3598","authenticated-orcid":false,"given":"Eric I.","family":"Benchimol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"deBruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly A.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pham-Huy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia H.","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa L.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talat","family":"Bessissow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Carman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil Y.","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto G.","family":"Vanderkooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2020.12.079_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1572-0241.2006.00646.x","article-title":"Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses","volume":"101","author":"Melmed","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.079_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10620-010-1329-8","article-title":"Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?","volume":"56","author":"Selby","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.12.079_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.MIB.0000437737.68841.87","article-title":"Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: An opportunity for improvement","volume":"20","author":"Wasan","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2020.12.079_bib5","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.3748\/wjg.v21.i40.11273","article-title":"Immunogenicity and mechanisms impairing the response to vaccines in inflammatory bowel disease","volume":"21","author":"Mar\u00edn","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.079_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG clinical guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.079_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.079_bib11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1053\/j.gastro.2021.04.034","article-title":"Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)\u2013Part 2: inactivated vaccines","volume":"161","author":"Jones","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.079_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2020.12.079_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2020.12.079_bib14","series-title":"Clinical practice Guidelines We Can Trust","author":"Graham","year":"2011"},{"key":"10.1053\/j.gastro.2020.12.079_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Schunemann","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2020.12.079_bib16","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2020.12.079_bib17","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2020.12.079_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2020.12.079_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jclinepi.2014.12.011","article-title":"Guideline panels should not GRADE good practice statements","volume":"68","author":"Guyatt","year":"2015","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1053\/j.gastro.2020.12.079_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ibd\/izy232","article-title":"Frequency of herpes zoster vaccination among inflammatory bowel disease patients","volume":"25","author":"Khan","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10620-017-4716-6","article-title":"Rates and predictors of vaccinations among inflammatory bowel disease patients receiving anti-tumor necrosis factor agents","volume":"63","author":"Hung-Viet","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.12.079_bib22","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ibd.21591","article-title":"Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007)","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib23","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1097\/MIB.0000000000000905","article-title":"Health services utilization, specialist care, and time to diagnosis with inflammatory bowel disease in immigrants to Ontario, Canada: a population-based cohort study","volume":"22","author":"Benchimol","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/ecco-jcc\/jjv064","article-title":"Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake","volume":"9","author":"Malhi","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.079_bib25","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/MIB.0000000000000425","article-title":"Strategies to improve influenza vaccination in pediatric inflammatory bowel disease through education and access","volume":"21","author":"Huth","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib26","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1007\/s10620-015-3631-y","article-title":"Effect of immunosuppressive therapies for the treatment of inflammatory bowel disease on response to routine vaccinations: a meta-analysis","volume":"60","author":"Nguyen","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.12.079_bib27","first-page":"90","article-title":"Using computerized physician order entry to ensure appropriate vaccination of patients with inflammatory bowel disease","volume":"16","author":"Karr","year":"2016","journal-title":"Ochsner J"},{"key":"10.1053\/j.gastro.2020.12.079_bib28","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib29","first-page":"CD004407","article-title":"Vaccines for measles, mumps and rubella in children","author":"Demicheli","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2020.12.079_bib30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.vaccine.2017.01.048","volume":"35","author":"Croce","year":"2017","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2020.12.079_bib31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10620-018-5321-z","article-title":"Immunosuppression does not affect antibody concentrations to measles, mumps, and rubella in patients with inflammatory bowel disease","volume":"64","author":"Caldera","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.12.079_bib32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/ibd\/izy366","article-title":"Serologic status of routine childhood vaccines, cytomegalovirus, and Epstein-Barr virus in children with inflammatory bowel disease","volume":"25","author":"deBruyn","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib33","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1007\/s10620-016-4275-2","article-title":"Many inflammatory bowel disease patients are not immune to measles or pertussis","volume":"61","author":"Cleveland","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.12.079_bib34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ibd.23027","article-title":"Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD","volume":"19","author":"Naganuma","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease","volume":"4","author":"Cheent","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2020.12.079_bib36","first-page":"S131","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States","volume":"189","author":"Zhou","year":"2004","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/02813430510031306","article-title":"Parents' reported reasons for avoiding MMR vaccination","volume":"23","author":"Dannetun","year":"2005","journal-title":"A\u00a0telephone survey. Scand J Prim Health Care"},{"key":"10.1053\/j.gastro.2020.12.079_bib38","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ypmed.2019.03.033","article-title":"Socioeconomic status differences in parental immunization attitudes and child immunization in Canada: findings from the 2013 Childhood National Immunization Coverage Survey (CNICS)","volume":"123","author":"Carpiano","year":"2019","journal-title":"Prev Med"},{"key":"10.1053\/j.gastro.2020.12.079_bib39","first-page":"1909","article-title":"Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: a systematic review and meta-analysis","volume":"12","author":"Tabacchi","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1053\/j.gastro.2020.12.079_bib40","first-page":"2624","article-title":"Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: a phase III, randomized study","volume":"14","author":"Abu-Elyazeed","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1053\/j.gastro.2020.12.079_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.gastro.2020.12.079_bib42","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1017\/S0950268817001546","article-title":"A\u00a0systematic review of varicella seroprevalence in European countries before universal childhood immunization: deriving incidence from seroprevalence data","volume":"145","author":"Bollaerts","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1053\/j.gastro.2020.12.079_bib43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0891-5520(05)70316-0","article-title":"Clinical trials of varicella vaccine in healthy adolescents and adults","volume":"10","author":"Arbeter","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"10.1053\/j.gastro.2020.12.079_bib44","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.cgh.2017.12.052","article-title":"Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study","volume":"16","author":"Khan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.079_bib45","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.cgh.2018.05.024","article-title":"Increased risk of herpes zoster infection in patients with inflammatory bowel diseases in Korea","volume":"16","author":"Chang","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.079_bib46","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: Implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.gastro.2020.12.079_bib47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijcp.12508","article-title":"Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study","volume":"69","author":"Tsai","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1053\/j.gastro.2020.12.079_bib48","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2020.12.079_bib49","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.079_bib50","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/ibd.22950","article-title":"Varicella zoster virus infection in inflammatory bowel disease","volume":"18","author":"Cullen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2015.12.072","article-title":"Hospitalization for varicella and zoster in children with inflammatory bowel disease","volume":"171","author":"Adams","year":"2016","journal-title":"J\u00a0Pediatr"},{"key":"10.1053\/j.gastro.2020.12.079_bib52","series-title":"Systematic Review of Available Evidence on Effectiveness and Duration of Protection of Varicella Vaccines","year":"2013"},{"key":"10.1053\/j.gastro.2020.12.079_bib53","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2020.12.079_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e31821e1917","article-title":"Varicella immunity in inflammatory bowel disease","volume":"53","author":"Ansari","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2020.12.079_bib55","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz295","article-title":"Varicella virus vaccine live: a 22-year review of postmarketing safety data","volume":"6","author":"Woodward","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib56","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2004.41389_7.x","article-title":"Disseminated primary varicella after initiation of infliximab for Crohn's disease","volume":"99","author":"Leung","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2020.12.079_bib57","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1086\/522135","article-title":"An economic analysis of the universal varicella vaccination program in the United States","volume":"197","author":"Zhou","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib58","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jiy418","article-title":"Point-counterpoint: the Hope-Simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence","volume":"218","author":"Harpaz","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib59","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2012.05.050","article-title":"Review of the United States universal varicella vaccination program: herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data","volume":"31","author":"Goldman","year":"2013","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2020.12.079_bib60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1651-2227.2007.00118.x","article-title":"Parent-dependent barriers to varicella immunization in Israel: the importance of adequate information","volume":"96","author":"Adler","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.gastro.2020.12.079_bib61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/1203475418811335","article-title":"Vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies","volume":"23","author":"Papp","year":"2019","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1053\/j.gastro.2020.12.079_bib62","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0140-6736(85)92443-2","article-title":"Immunisation of nurses with a live varicella vaccine","volume":"1","author":"Ndumbe","year":"1985","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2020.12.079_bib63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1542\/peds.78.4.757","article-title":"Live attenuated varicella vaccine use in immunocompromised children and adults","volume":"78","author":"Gershon","year":"1986","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2020.12.079_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/158.1.132","article-title":"Immunization of healthy adults with live attenuated varicella vaccine","volume":"158","author":"Gershon","year":"1988","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib65","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/0264-410X(95)00046-4","article-title":"Safety, tolerability, and immunogenicity of two regimens of Oka\/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka\/Merck Varicella Vaccine Study Group","volume":"13","author":"Kuter","year":"1995","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2020.12.079_bib66","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/512673","article-title":"Strategies to prevent varicella among newly arrived adult immigrants and refugees: a cost-effectiveness analysis","volume":"44","author":"Merrett","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib67","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2005.06.004","article-title":"Cost-effectiveness of varicella vaccination of healthcare workers","volume":"23","author":"Chodick","year":"2005","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2020.12.079_bib68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2016.04.002","article-title":"Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection","volume":"151","author":"Julsgaard","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.079_bib69","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ecco-jcc\/jjy142","article-title":"Outcome of pregnancies in female patients with inflammatory bowel diseases treated with vedolizumab","volume":"13","author":"Moens","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.079_bib70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5217\/ir.2018.00071","article-title":"Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children's immunity","volume":"17","author":"Lee","year":"2019","journal-title":"Intest Res"},{"key":"10.1053\/j.gastro.2020.12.079_bib71","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ibd\/izy294","article-title":"Safety of anti-TNF-alpha therapy during pregnancy on long-term outcome of exposed children: a controlled, multicenter observation","volume":"25","author":"Duricova","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of biologic therapy by pregnant women with inflammatory bowel disease does not affect infant response to vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.079_bib73","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fimmu.2017.01123","article-title":"Immunological changes in blood of newborns exposed to anti-tnf-alpha during pregnancy","volume":"8","author":"Esteve-Sole","year":"2017","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2020.12.079_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.MIB.0000440984.86659.4f","article-title":"Impact of anti-tumor necrosis factor alpha antibodies administered to pregnant women with inflammatory bowel disease on long-term outcome of exposed children","volume":"20","author":"Bortlik","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib75","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2036.2011.04617.x","article-title":"High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy","volume":"33","author":"Zelinkova","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2020.12.079_bib76","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cgh.2012.11.011","article-title":"Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.079_bib77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41424-018-0018-3","article-title":"Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants","volume":"9","author":"Kattah","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.079_bib78","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ecco-jcc\/jjy053","article-title":"Hepatitis B vaccination effective in children exposed to anti-tumour necrosis factor alpha in utero","volume":"12","author":"de Lima","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.079_bib79","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.079_bib80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/2012\/327054","article-title":"Cost effectiveness of infant vaccination for rotavirus in Canada","volume":"23","author":"Coyle","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1053\/j.gastro.2020.12.079_bib81","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1542\/peds.2006-2876","article-title":"Cost-effectiveness and potential impact of rotavirus vaccination in the United States","volume":"119","author":"Widdowson","year":"2007","journal-title":"Pediatrics"},{"key":"10.1053\/j.gastro.2020.12.079_bib82","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1016\/j.vaccine.2017.04.051","article-title":"Global economic evaluations of rotavirus vaccines: A systematic review","volume":"35","author":"Kotirum","year":"2017","journal-title":"Vaccine"},{"key":"10.1053\/j.gastro.2020.12.079_bib83","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4161\/hv.24253","article-title":"A\u00a0critical literature review of health economic evaluations of rotavirus vaccination","volume":"9","author":"Aballea","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1053\/j.gastro.2020.12.079_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2431-7-32","article-title":"A\u00a0qualitative assessment of factors influencing acceptance of a new rotavirus vaccine among health care providers and consumers","volume":"7","author":"Patel","year":"2007","journal-title":"BMC Pediatr"},{"key":"10.1053\/j.gastro.2020.12.079_bib85","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/her\/cys088","article-title":"Determinants of parents' decision to vaccinate their children against rotavirus: results of a longitudinal study","volume":"27","author":"Dube","year":"2012","journal-title":"Health Educ Res"},{"key":"10.1053\/j.gastro.2020.12.079_bib86","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ecco-jcc\/jjaa099","article-title":"Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease","volume":"14","author":"Park","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.079_bib87","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2020.12.079_bib88","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/infdis\/jiq031","article-title":"Immune responses to rotavirus infection and vaccination and associated correlates of protection","volume":"203","author":"Desselberger","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2020.12.079_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/14760584.2019.1559063","article-title":"Current perspectives in assessing humoral immunity after measles vaccination","volume":"18","author":"Haralambieva","year":"2019","journal-title":"Expert Rev Vaccines"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521004273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521004273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:50:15Z","timestamp":1762163415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521004273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0016508521004273"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2020.12.079","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)\u2014Part 1: Live Vaccines","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2020.12.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}